Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
NCT00314925
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoid
Neuroendocrine
Interventions
DRUG:
Seneca Valley Virus (biological agent)
Sponsor
Neotropix